Global Hereditary Angioedema market size is expected to reach $4.15 Billion by 2030 at 8%, rising prevalence of rare diseases driving the growth of the market due to increasing demand for specialized treatments
Read MoreGlobal Herceptin market size is expected to reach $9.92 by 2030 at 5.8%, increasing incidence of breast cancer fueling the growth of the market due to rising patient cases and demand for targeted therapies
Read MoreGlobal Herbal Shampoo market size is expected to reach $8.83 by 2030 at 7.5%, surge in e-commerce driving the growth of the market due to increasing accessibility and consumer convenience
Read MoreGlobal HER2-Positive Breast Cancer market size is expected to reach $15.23 billion by 2030 at 6.8%, impact of immunotherapy adoption on the her2-positive breast cancer market
Read MoreGlobal HER2-Negative Breast Cancer market size is expected to reach $25.41 billion by 2030 at 7.6%, rising breast cancer incidence drives growth of the market
Read MoreGlobal Hepatorenal Syndrome market size is expected to reach $1.91 Billion by 2030 at 6.9%, rising prevalence of liver diseases driving the growth of the market due to increasing risk of kidney dysfunction
Read MoreGlobal Hepatitis Diagnostic Tests market size is expected to reach $6.6.72 billion by 2030 at 6.6%, segmented as by blood tests, serological tests, polymerase chain reaction (pcr) tests, enzyme-linked immunosorbent assays (elisa)
Read MoreGlobal Hepatitis D market size is expected to reach $0.93 billion by 2030 at 4.1%, rising hepatitis b prevalence fuels growth in the market
Read MoreThe hepatitis C testing market will grow from $1.78 in 2025 to $1.32B in 2026 at 6.1% CAGR, driven by rising disease prevalence and expanding health programs.
Read MoreThe hepatitis C market is projected to reach $153.67 billion by 2030, growing at 15.4% CAGR, driven by direct-acting antivirals, early screening, and expanded access to treatment.
Read More